Clinical Trial

The Bioavailability and Effect on Pouch pH of Esomeprazole After Gastric Bypass

Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The objective of this study is to investigate the effect of Esomeprazol administered in tablets (Esomeprazol MUT Sandoz® 40mg) or in solution (Esomeprazol MUT Sandoz® 40mg in 10ml tap water) on acid production in the gastric pouch by measuring the intragastric pH and the serum concentration of esomeprazole.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2022-04-06; most recent amendment 2026-06-08.
Status change: Not Yet Recruiting → Recruiting 2023-11-23
Trial Details
NCT Number NCT05320796
Lead Sponsor Prof Urs Zingg
Conditions Obesity, Gastric Reflux, Ulcer, Gastric
Enrollment 50 participants
Start Date 2023-11-01
Primary Completion 2027-12-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-06-09